共 101 条
[1]
Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[2]
Miller KD(2014)Rhabdomyosarcoma in adolescent and young adult patients: current perspectives Adolesc Health Med Ther 5 115-125
[3]
Jemal A(2001)Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease J Clin Oncol 19 3091-3102
[4]
Egas-Bejar D(2011)Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee Int J Cancer 128 1232-1239
[5]
Huh WW(2009)Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803 J Clin Oncol 27 5182-5188
[6]
Crist WM(2003)Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group Cancer 97 2597-2604
[7]
Anderson JR(2011)Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group Cancer 117 3493-3501
[8]
Meza JL(2005)Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee J Clin Oncol 23 4363-4371
[9]
Rodeberg DA(2017)Comorbidity and quality of life in childhood cancer survivors treated with proton beam therapy Pediatr Int 59 1039-1045
[10]
Anderson JR(2016)A retrospective evaluation of the benefit of referring pediatric cancer patients to an external proton therapy center Pediatr Blood Cancer 63 262-269